Kathy de Graaf

Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Claudia Bracaglia, Kathy de Graaf, Denise Pires Marafon et al. · Annals of the Rheumatic Diseases · 2016 · 291 citations

Medicine, Immunology, Pathology +17

Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS

Emmanuel Monnet, G Lapeyre, Eveline P. van Poelgeest et al. · Clinical Pharmacology & Therapeutics · 2016 · 77 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Energy intake and body weight effects of six months reduced or full fat diets, as a function of dietary restraint

MS Westerterp-Plantenga, NEG Wijckmans-Duijsens, WPG Verboeket-van de Venne et al. · International Journal of Obesity · 1997 · 75 citations

Agriculture, Nutrition, Nutritional Sciences +16

Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study

Emmanuel Monnet, Ernest Choy, Iain B. McInnes et al. · Annals of the Rheumatic Diseases · 2019 · 71 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

OP0204 EMAPALUMAB, AN INTERFERON GAMMA (IFN-Y)-BLOCKING MONOCLONAL ANTIBODY, IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)

Fabrizio De Benedetti, Paul Brogan, Alexei A. Grom et al. · Annals of the Rheumatic Diseases · 2019 · 34 citations · Full text

Life Sciences, Immunology, Pharmacokinetics +17